PEUEH3M8. TpyA 3a npmaogwaane na o6pa3obare/iha M HayMHa crenen,,aoktop" Aerop H3 AncepraMHOHHus TpyA: KDpMM Herpes K/iwcapOB

Size: px
Start display at page:

Download "PEUEH3M8. TpyA 3a npmaogwaane na o6pa3obare/iha M HayMHa crenen,,aoktop" Aerop H3 AncepraMHOHHus TpyA: KDpMM Herpes K/iwcapOB"

Transcription

1 PEUEH3M8 TpyA 3a npmaogwaane na o6pa3obare/iha M HayMHa crenen,,aoktop" Aerop H3 AncepraMHOHHus TpyA: KDpMM Herpes K/iwcapOB Tewa na Anceprai4noHHWfl na o6ynehmeto no neaarormheckmie AHci4nrmMHM B cbotbctctsme Cbc crwia na : AOU6HT AOKTOp 1. AKryanHOCT Ha pa3pa6otbahmfl B A^cepTau,noHHMfl TpyA npo6/iem s Haynno M npm/iomho othoiuehne. CreneH M nwea Ha aktya/ihoctra Ha npo6/iema M KOHKPCTHM TB B na o6ymehneto e BAMH or nepeuiehmte npo6/iewn B npaktmka M acflna nayhha paspasorna B Toea Hanpas/ieHMe e He camo SKTya^na, HO M npeanoctsbka aa peiuasaheto My. M/weHHO B Toea ce Cbcrow M akrya/ihocrra na TpyA na r/iaseh acmctenr K)pnii HeTpos H.e/i na pa6otara e AS ce o6ochobe M A Ka>Ke e^ektmbhocna na o6ymehme B ci>otbetctbme c MHAMBHAya/iHWH ctm/i Ha ynche. 3a npaktmhecna pea/iwaaumfl ca M36paHM neaarornneckmte AwcuMn^MHM, HO rosa HM Haii-Ma^KO ne orpahmsaaa M3no/i3BaHeTO Ha nocrnrh3tmte pesy/itarn M np«o6ymehh6to no wn>kehephwte na Hsc/ieABaneTO cbmo ca aktya/ihm. ntpsara aaaana ^PIpoyHBaHe Ha npo6nema" e aktya/ina, TbM KBTO y Hac MHOro wa/iko ca pa3ps6otkmte M npoyhbanmnra B T33M Hacona. BTopaTa saaana j^a ce wsc/ieaba cawoctoflte/ihata pa6ora na CTyA^HTMTe B cemmhaphmte aanathfl no neaarorh46ckhte AUCHMR/IMHH B cbsaaaenara or asropa BapwaTMBHa cpeaa sa AM(j>epeHu,HpaHO o6ynehme B cbotsetctewe c MHAMBHAVa^HMR CTM/I Ha pa6ot3" e 0146 no aktya/ina B\>B Bp~b3K3 c HaB/iM33H6TO na e/ienrpohhhte MOTOAM 33 o6ymehne M AncraHUMOHHOTo o6yhehne. flpw mx cawocrowte/ihata pa6ota Tpfl6sa Aa crane ochosna 4>opMa M MOTOA Ha o6yh6hwe, B T33H Bpt3Ka BCMHKM M3CyieABaHM«V( p33pa6otkm S T33M nocoka Ca MHOfO aktya/lhm M npsktmko 3H3HHMM. TpCTaTB 33AaM3,,fl,a C6 M3OieABa OTHOUJeHMeTO Ha CTYAeHTMTe KtM CT>3AaAeH3Ta cpeaa 3a AM<j>epeH^^1paHO o6ymehne B ctotsetctbhe c nham8maya/»hmte crmyioae na ynehe" e no cbu^ecrbo M3c^eA8aHe OTHOLueHMCTO na ctyachtmte K^M cawocroate/ihats pa6ota, a KocBeHo M H3c/teA83ne MS TexHHTe MOTHBM M Har/iacw 33 ysene. TasM saaama e oco6eho 3KTya/)Ha 3a peujaeane npo6/iewmte c MHAMBMAya/'HoTo o6u4ybane,,npenoa3bate/i-ctyaeht". 06iMVBaHe, Koero B KOHT6KCT3 Ha rpynobmie 4>opMM Ha o6yh6hme <j)aktmheckm ce cee>t<a3 AO BtnpocM (npwc-hctbwe/otcbctbme; sasepkm; TCKyu; KOHTpo/i M T.H.). pa6ota M no^o>kmte^hmte nar/iacn OT ctpaha na cryaehthte 33 vtsa-bptubaheto M ca npeanoctabka TaxHara atcrnbhoct M nsno>i3baheto na MHTepaKTHBHM MCTOAM 3a o6yh6hme BMecro npeo6/iaaabat4mte no Hacroame nacmbhh penpoayktmbhm MCTOAH- DocneAHaTa

2 ,/la ce cpabhrt pesy/ttatvite OT anpo6wpahhte sapwahtm na A^epeHi^MpaHO ogymenwe a 33BMCWMOCT OT MHAMBMAYa/lHUfl M AOMMHaHTBH CTM/1 H3 ym6h6 B CeMMHapHMTe 33HHTHfl OeAarornKa M MeTOAnna Ha o6yhehheto no TexHMMecHMTe Ancu,nn/WHn" wwa OTHOiueHMe AOK33B3He H3 xmnotcsata na A^cepTauMOHHMfl fpya-»akq osynehmeto no AMOjMn/iMHW ce An4>epeHHMpa B aaencumoct OT MHAMBMAya/iHua CTM/I Ha ynehe TO 146 ce pe3y/it3tmte QT camoctoflte/mata pa6ota na ciyaehthte M THXHOTO yaob/ietbopehne no 2. CreneH Ha noshasane CT>CTO«HMCTO Ha npo6/iewa H TeopsecKa MHTepnpeTauMfl na ABTopisT e HanpaBM/i wnoro 3aAWi6oMeno npoymsahe na oieahmte npo6/iemn: KOHCTpyKTMBM3Ma; K3TO T6OpH«33 yh6he H3 6a33T3 H3 ORVlTa; MOAG/IM H3 npenoa3bah6 M ymbhc na 6aaa KOHCTpyKTMSHSMa; Teopns Ha ekcnepnehuma/ihoto y4ene; CTvt/ioBe HB ynene; o6ynehiie; crm/ioee na npenoaas na o6ymehneto M cawioctonte/ihata pa6ota na ca amepmkanckhfl, eeponescknn M 6virapcKMfl ORHT no T63M npo6/iemm. e nok33a/i 3aA^«6oMeHM noanahnn M aha^mtmmeh noaxoa K"bw npo6/iemmte B na, noeto M36npa KOHCTpyKTHBwsivia, KaTo TeopeTMHHa ocnoea He CBOS AMcepTaunoHeH, K3KTO M npouecya/thwa MOAe/ia na A Ko/i6 nopaah HerosaTa npaktmnecka npm/iownoct B P33/IMHHM npeamcthm O6/13CTM ca 3aAi>i6oMeHn M aha/imthmhm, M ca no3bo/in/in na aeiopa M3BOAM, KOMTO npasm/iho Aa ohepta«t cfecto«hmeto Ha npo6/iewa B naiuata npaktmka M HaMepTae HacouwTe 33 nerosoto petuabane. H ctm, ne topmm K^ncapos B peay/itat na ce e o<t>opmm/i, KaTo cnei^wa/ihcr no A^epeHUMauMfl na o6ymehm6to sva OCHOBB na MHAMBMAVa/lHUTe CTM/1OB6 H3 yhche M MM3 Bl>3MO>KH OCTM A3 C6 p338mba M B HayMHO M npm/10>kho Hanpaanenne 33 B 3. C"bOTBeTcrsne na M36paHaTa MeToAHKa Ha wac/ieabahe c noctaaehata i^eji M saaann na TpyA- H3C/ieABaneTO na noctasenmte ue/in M 33A3HH e M3B-bpiueHo, KBTO c ekcnephmeht3/ihh M KOHTPO/IHM rpynm. EKcnepHMenrbT e n/ishmpsn M cbr/iacho M6TOA«KaTa sa nposewaahe na neaarornmeckm Ha AMcePT3UMOHHnn TPYA MHAHBMAya/i«3ai4Mfl H3 o6ym6hmeto e 3a camocroflte/wa pa6ota w e^ektmbhocrra e AQKasana Mpes OCHOBHM M6TOAH H3 M3C/ieAB3H6TO M3nO/13BaHH B p33pa6otkat3 C3! 3H3/iMTM4eH anatims, Ha6/iioAeHMe, neaarortmeckm ekcnepmmght, ahketa, AMAaKTMnecKn TecroBe. 4. Ana/iHTHMHa xapaktepmcthka H3 ecrecrsoto v\a na AocroBepHOcrra na MarepMana, Btpxy KOMTO ce rpaa«t nphhochte Ha AwcepTai4MOHHHfl

3 Ha AwcepTaHMOHHMH TpyA ce rpaa«t na pesy^iatmte OT ekcnepmmcht. Msno/isBaHMie B nero MarepMa/iM aa camocroare/iha pa6ora M34H/1O ca B cbotbetctbue c yneshmte u,enu M yme6horo CbAtpHOHMe no AMcUMruil1HMTe w MBTOAMKS na o6ym HneTO no TexHMMeCKwre AMcnnn/tMHW. EKcnepMMeHTtT e no speme Ha pea/ien yme6en npoi^ec w a cbqteetctbme c yme6hmte nporpamm. 5. HayMHM M/H/IM HayHHo-npn/io>«HM npmhocm Ha KBTO HayMHM M HayMHO npunowhm npunocm abtoptr e HOCOMW/I HCT npmhoca, 6e3 Aa, KO6TO cnopea MCH e nponycn. A3 /IHMHO npnewiam, Me BCMMKMTC HCT npmhoca ca T npmhoc, pa3pa6otb3heto na Hoea ctparerhh 33 AH4>ePeHL^MPaH o6yhehne na 6asa TeopwflTa Ha A Ko/i6c M npouecya/ihms MOAC/I Ha cmna na ymche e no c*opo MeioAnna 33 An<J)epeHi4np3HO o6ymehne. MeTOA^KaTa BK^tOMBa: onpeaenrhe na nhambmava/ihmte CTM^iose 33 ynene; KOHKpeiMsauMHTa na u,e^nre Aa o6ym Hne s cbotbetcrswe c MHAMBMAya/iHMTe crwyiobe 33 ymene; paspa6otb3he na 33A3MM sa camocroflte/iha pa6ora M omchflb3he na pesy/iratmte (ryn CT3B3 B^npoc 3a ol46h«bahe Ha no/iymehmr npoaykt, a 3a B 6-bAeuje e neo6xoamma npoi^eaypa 33 na pesy/iratmte T npwhoc, AOKaaBane Ha epi>3kata MOKAV CTM/ia na ynene, crpatermmte 33 npenoaasane M e4>ektmbhocrra Ha camoctoflte/inara pa6ot3, cbiuo e HayMHO npn/ioweh. ll^e Hanpaea 3a6e/ien<HaTa/ MB AOKassaneTO na T33M Bpi>3Ka TpflSea Aa 6"bAe pasr/iewaano B KOHteKcra na pe3y/iratmte OT o6yhehmero. B CMMCT*/] nosumabaheto na KaMecreoTO My, npmhoc, A xa36ahe ecfjektmbhocrra Ha A^^P^HU^paHOTO o6ym HHe 6 3aancn/v\ocT OT awia na ymene B^B sapmarhbha A^AaKTHMecxa cpefta MMa MHOFO snanehme aa npaktmkata, TT>M Karo npeactae/wba MeTOAWHecna ocnosa na Ha o6ym6hheto. nonacroflimem AWAaKTMHecKaTa cpea3 ce w3rpah<aa or ryieaha TOHKB na 4e/iMTe na o6ym6hme M cbotsethara npeametha o6/iact. OCBBH Tosa Taaw cpea3 ce M3rpa>KAa npwopmtetho 33 rpynobm (J>opMn na o6ym6hne npmhoc AOKasBaHe no-tomhara A^arHOCTUHHa cw/ia na CKa/iaTa Ha fl.ko/i6 B a>c CKa/iaTa na Xt>Hw-MtM(J>QpA noa/ie>km na Aont/iHMTe/iHO AO*<a3aTe/icTBO c M pasujhpnaaheto na wsc/ieasahmflta. PlpneiviaM ro HO B-bnpocbT TbpnM pasbmtwe M npmhoc, ce OTHacfl AO pa3pa6ot6hhte A^AaKTMHecKM MaTepna/in aa AM(i>epeH^npaHo o6ymehme B sasmchmocr OT MHAMBMAya/innTe CTM/toae sa YMCHC M MHCTpyMCHTapnyM sa npobewaannfl neaarornmeck«e/ieweht. Pa3pa6oT6HMTe A^aKTMseCKn MaTepna/w ca npeanoctabka 33 GtAeu^a pa6ota aa pa3pa6otbah6to Ha MeTOAMKa sa na AMAaKTiiMecKM MaTepna/in 33 AH<t>epeHUMpaHO o6ym6hme. 6. OneHKa 33 crenehta na /IMHHOTO ynacthe Ha AncepraHTa B npnhocnre. ^OKTOpCK3Ta pa6ot3, K3KTO M HpMHOCMTe KbM H6fl C3 M3L\a/lO A^/IO H3 f/lbbeh 3CMCT6HT

4 7, npeu,ehk3 na ny6/imkau,mmte no AwcepTauMOHHMH TpyA: 6poft, xapakrep na M3AaHmrra, B KOMTO ca otnenatahm, OTpaweHMe B HayKara - nano/iasane M umnpane OT Apyn abtopw, B APY, ctpahm M np. Ho AHcepTai MOHHMfl TpyA ca nanpaeehm 8 ny6/ihk3umm, warrb/iho AOCTarbHHM 33 cnopea H3MCK83HMflT3 B TY-CO(J)Mfl U.MT3 H3 riy6/iwkau,mhte ca B C6opnwKa na LUywieHCKwn neaarotm^eckh MHCTMTYT - 1 6pow, KoH(t>epeHu,MRTa na UJyMeHCKMfl neaaroameckm tihctmtyr,,mhobau.nn B o6pa3obahh6to - 1 6poM H3 o>io33 na ynenmte B B-b/irapna-6 6pon. He ca nocomchm M He ca MM MaseCTHvi ^THPSHMS OT APY, ne e HeoSxoAMMO peay/itatmte OT TpyAa A3 ce ny6/wkyaat M B sy>k6mha, B 8. H3no/i3Bane na pesy^tatmte OT AMcepTauMOHHMfl TpyA B HaynnaTa H cou.ua/ih3ta Pe3y/iT3TMTe OT A^cepTanMOHHMR TpyA MOPST A3 ce wsno/iseat B yne6hmfl npou.ec na Mn<l>- C/JMB6H Ha Ty-Co4>WH no BCMMKM neaarofhheckm AMCu,HanMHM. CnopeA wen H«Ma npo6/iem 33 M3no/i3BaH6TO Ha pe3y/it3tmte M B o6ym6hmeto no TexHMMecKMTe AHCU.HfwuHH c/iea anpo6au,hh c B cbotsethmte TOB3 lu,e nobmujh MOTMBaU,MaT3 Ha CTyA6HTMTe H ll^e Ce noao6pm KSHeCTBOTO H3 ym66hmfl npou.ec.,qm4>epehump3hoto odymehme ua.e peujm M npo6/iem-bt c Hesi>3MO>KHOCTT3 na HSCT OT Aa ynactsat H rpynobmte (J>opMM na osynehwe nopaam aaetocr c pa6ota. 9, Ot4eHKa H3 CbOTBeTCTBM8TO H3 3BTOpe4>epaT3 C M3MCKBaHWflTa 33 M3rOTBflH6TO My, K3KTO M H3 H3 OTp33flB3He H3 OCHOBHMTe no/loh<ehhr M npmhocmtc H3 AMCepT3U,MOHHHfl ABTOpe<t>ep3TbT M31VI/1O CbOTBCTCTBa C M3MCKBaHHf1Ta 33 HefOBOTO M3fOTB«He M npeact3bfi OCHOBHMTe no/!o>kehmfl H npmhocm H3 10. MHenun, npenop-bkm M 6e/ie>KKM. 1. CMHT3M, ne AMcepTauMOHHMfl TpyA, KaKTo H neflarormmeckata npaktmka 6Mxa cnene/iw^m abtoptt 6e npea/iowm/i wetoamna 3a pa3pa6otbane na saaammte aa cawoctoflte/inata pa6ota s 33BMCMMOCT OT MHAMBMAya/iHMfl ctm/i Ha ysehb. npenopi>hbam TOBa f(3 6oAe nvpsata 33Aana Ha abtopa c/iea sai^mtata. TOBB 6M IIOSBO/W/IO BHeApisane na HaynHO npm/iownwte MHoro /iecho M B APYrH npeamethm o6/iactm. 2. B AMcepTau,naTa MeTMpMTe CTM/ta Ha ynene ca npeactasehm K3KTO Ha crpyktypho Tana M na (j)yhku,moha/lho HMBO. TOB3 e M3nO/13B3HO OT 3BTOp3 33 MSfpaWAaHCTO H3 B3PM3TMBH3 pea3 {33AaMMTe 33 CaMOCTOnTe/IH3 pa6ot3). MHC/lfl, H6 e Heo6xOAMMO TOB3 M3no/i3Ba M na oprahmsaunohho HMBO npw nposemaahe na odynehmcto, no TOMHO yneneto M ou,ehka na

5 3. Rpenop-bMBaM na m. ac. tophm K/incapos Aa npoa*».n>km M3oieA8aHMRTa CM M npn/iomehmero MM B yme&hmfl npoitec M aie& sammtaia, KSTO paaujwpw TSXHOTO npw/iomehme 8 <j)opmm na o6ymehmeto, KOMTO npeacroay Aa ce c/iynar a Haiunn 4. CnoMenax BCMG, ne nphhocwre He ca pasae^ehm Ha naynnm M npn/iomhn M as npwemam, we roaa e raka 33^010 re ca cawo HayHHo-npn/io>«HM, 11. 3aK/iK>HeHne. B 3aK/iK)HeHMe ouenkara MM sa AncepTaunoHHUflr TPVA Ha r/iaseh acmcreht KDpuM nerpoa K/iMcapos e no/iowme^ha. CMfliaM, ne Tpyflvr M3ua/io yaob/ieibopflsa MancKBaHUflTa Ha aakoha 3a HayMHMre crenehm M aeahwa n flpaan/ihhka Ha Ty-Co<t)HR 3a AOKropcna AMceprauMfi M Ha yeawaemoro wypm A3 r/iacyea Ha aeropa Aa 6tAe npncbaena o6pa3oeaie/ihocrenen,,aoktop". A A / : r. PE14EH3EHT: v_x,-a-pkp. Cniipos)

IIPOTOKOJI.N!! 1. Ha a.n;m.f?l>kobo.[(hteji-okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha

IIPOTOKOJI.N!! 1. Ha a.n;m.f?l>kobo.[(hteji-okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha IIPOTOKOJI.N!! 1 OT 3ace.n;amrn Ha KOMHc1u1Ta, Ha3HaqeHa enc 3aIToBe.n; NQ P,[(-04- l 68/24.08.20l5r. Ha A.n;MHHHCTpaTHBHH51 pokobo.[(hteji - okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha ITpoKypaTypa Pyce, 3a co6hpahe,

More information

.ao. all1pektopa Ha V1V1T - 6AH

.ao. all1pektopa Ha V1V1T - 6AH 1 8. 06. 2iJ1Q.ao all1pektopa Ha V1V1T - 6AH HHcmnrr no H" OPM. TEXHOnOfHU SAJ-f C0::l>MH., ( ax. N!!.!.....1.4..".keho BVI Vl3npaL.LtaM npenvlc~vl3ene4ehvle

More information

November 09, Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the

November 09, Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the Digital Archive International History Declassified digitalarchive.wilsoncenter.org November 09, 1982 Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the Communist

More information

-- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /"v

-- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /v IIA P() Br.No II(} CIII;tr'AII[IE nu u Ao -- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /"v T.XA IIEIIKA IIATIEBA Y ybaxaema rociioxo IPEACEAATEJT, Ha ocnosahre qjr. 8'1, a* 1 or Koscrvryr\uflTa

More information

ytbbpxaabam: 3AnOBEA rp. Bapxa,l0r.!/.,.. 2o 18r.

ytbbpxaabam: 3AnOBEA rp. Bapxa,l0r.!/.,.. 2o 18r. ::PAfrOH,,nPHMOPCKH" - O6Ull4HA BAPHA 9010 Bapna, 6yn.,,feuepan KoneB" Ns 92, ren: +359/52/359 100; Saxc 303 110 3AnOBEA Ne..Ll(... rp. Bapxa,l0r.!/.,.. 2o 18r. Ha ochoeahne L{.rt. 46 or 3MCMA, q.n, 6,

More information

*,{ /g t ll --.'r;i 8,' Ao TTPEACEAATEJTf, HA s5./ HAPoAHoro crbpahlie ly. r-xa TIBETA KAPA.flHTTEBA 6t. ybaikaema rociiox(o ITPEACEAATEJT,

*,{ /g t ll --.'r;i 8,' Ao TTPEACEAATEJTf, HA s5./ HAPoAHoro crbpahlie ly. r-xa TIBETA KAPA.flHTTEBA 6t. ybaikaema rociiox(o ITPEACEAATEJT, /g t ll --.'r;i 8,' Ao TTPEACEAATEJTf, HA s5./ HAPoAHoro crbpahlie ly *,{ r-xa TIBETA KAPA.flHTTEBA 6t ybaikaema rociiox(o ITPEACEAATEJT, Ha ourosauu,e ul. 87, ar. 1 or Koncruryr\trflTa ua Peuy6Jrr{Ka

More information

)(europoss. t4dea. Q 6tnrapm, UJyueH ,. no3 t-.i,lfl, 3A KOflTO KAM'I4ATCTBATE alltxhoct. AxperIop Aero rpa,qxha,?aneh Mal( - c.

)(europoss. t4dea. Q 6tnrapm, UJyueH ,. no3 t-.i,lfl, 3A KOflTO KAM'I4ATCTBATE alltxhoct. AxperIop Aero rpa,qxha,?aneh Mal( - c. )(europoss Asro6xorpaolae Co6creexo lme. flpe3xme. OaMr4nus nhqfla,4l-loopt Al-]t4fl t4dea [4nageloBa Q 6tnrapm, UJyueH - 9700,. E A E:AaI: non xefia laara Ha pamahe, '1985 I Hal{uohanHocr 6bnrapi,{i no3

More information

ABTOEhOfPAOt'1f. r Pyceea ro4raxa a LUyr'aex. Heonauxexa ctm, l4mam cnh Ha

ABTOEhOfPAOt'1f. r Pyceea ro4raxa a LUyr'aex. Heonauxexa ctm, l4mam cnh Ha ABTOEhOfPAOt'1f HA Henn r Pyceea aapec: rp.tljyuex, Po,qeHa cbm Ha 11 ro\nau. 1966 ro4raxa a LUyr'aex. Heonauxexa ctm, l4mam cnh Ha B ttouexra pa6orn a llly,,enncxon KoscraxrrH [lpecnaacrn"' Karo frlabeh

More information

060/ r. BoJInfrsoJrEH K4yE,,MLr. /ao. OP"_fP.tIEPH[IK AOKJIAAHA 3ATIIICKA. flpularau Br43yirnr43a:g;'z,vr c pa3rlojloxehl,iero Ha pekjiamhte Lt

060/ r. BoJInfrsoJrEH K4yE,,MLr. /ao. OP_fP.tIEPH[IK AOKJIAAHA 3ATIIICKA. flpularau Br43yirnr43a:g;'z,vr c pa3rlojloxehl,iero Ha pekjiamhte Lt BoJnfrsoJrEH K4yE,,MLr OP"_fP.tEPH[K 060/ r ttl- $ t).',0- W /ao TPEACEAATEJU HA OETTWCKVTCbB fp. [E,PH4K AOKJAAHA 3ATCKA Or YC ua BK,,MuHrop" - flepuzr OTHOCHO: flocransse Ha pekrlama YBA}KAEMA OCOAH

More information

CTAHOBIIIuN. F fipalblfr!fihaplrnoilfii #* gtt r# /{zo.({*. l. Kparrcu 6uorpaQnrnu AaEutr

CTAHOBIIIuN. F fipalblfr!fihaplrnoilfii #* gtt r# /{zo.({*. l. Kparrcu 6uorpaQnrnu AaEutr CTAHOBIIIuN lej_ BHCm yulllw II0 AI?0Br,[3EEC F fipalblfr!fihaplrnoilfii #* gtt r# /{zo.({*. zp.m0b$,!b om doq. d-p Ercamepuua flunumpoea Kncxueea-Apa1cxa Bucute yuunuu{e no azpo6uzuec u passumue Ha pezuohume

More information

NOTE: This table will be discontinued after this lot.

NOTE: This table will be discontinued after this lot. AS037-011 Rev. 11/14 ASSAY VALUES AND EXPECTED RANGES QCP DATA MONTHS: DEC, JAN, FEB Beckman Coulter STKS / MAXM / HMX LEVEL 1 + Lot No.: Exp. Date: LOT 871086 Parameter Mean Range WBC 10 3 /µl 4.0 ± 0.6

More information

,\BTOEHOTPAOH.fl. fi.irrxhocr: llne: Eoxr.rlapr? lo nunhurejrha r.ruqopruaunn: llor: xeha. HaunoHarHocr: Eurapxa

,\BTOEHOTPAOH.fl. fi.irrxhocr: llne: Eoxr.rlapr? lo nunhurejrha r.ruqopruaunn: llor: xeha. HaunoHarHocr: Eurapxa ,\BTOEHOTPAOH.fl llne: Eoxr.rlapr?, C'ro.sHoea Aapec: Ernrapur:, Te.neQoH: E-mail: HaunoHarHocr: Eurapxa fl.ara Ha par(aaue: 1955 r. lo nunhurejrha r.ruqopruaunn: llor: xeha Cemeftso rrojroxehue: ombxeha

More information

KOHL\Enl\"1R. 3A YnPABJ1EH"1E HA C"1CTEMATA "1 npo~eca HA fpaacko n11ah"1pahe..., fpaaoyctpolllctbehoto PA3B"1T"1E HA CTOJ1"14HA 06UJ.

KOHL\Enl\1R. 3A YnPABJ1EH1E HA C1CTEMATA 1 npo~eca HA fpaacko n11ah1pahe..., fpaaoyctpolllctbehoto PA3B1T1E HA CTOJ114HA 06UJ. KOHL\Enl\"1R 3A YnPABJ1EH"1E HA C"1CTEMATA "1 npo~eca HA fpaacko n11ah"1pahe..., fpaaoyctpolllctbehoto PA3B"1T"1E HA CTOJ1"14HA 06UJ."1 HA -.... -- -.. l.'bbbeaeh"1e B CbOTBeTCTBllle c ynpabjlehckara nporpama

More information

ENGINEER EQUIPMENT OPERATOR NCO Concept Card Report ANNEX B - EQUIPMENT OPERATIONS. Material Handling Operations (LRT-110, MAC 50, KALMAR)

ENGINEER EQUIPMENT OPERATOR NCO Concept Card Report ANNEX B - EQUIPMENT OPERATIONS. Material Handling Operations (LRT-110, MAC 50, KALMAR) METHOD HOURS S:I RATIO D 10.00 25 : 2 EM 26.00 25 : 2 L 17.00 25 : 1 PA 123.00 25 : 2 MEDIA: AIO, DB, HO, MCO, PPT, TM TERMINAL LEARNING OBJECTIVE(S) 1. Provided an engineer equipment requirement, engineer

More information

KOIlEKTIf1BEH TPY.QOB.QOrOBOP. TEXHIf1\..1ECKIf1 YHIf1BEPCIf1TET

KOIlEKTIf1BEH TPY.QOB.QOrOBOP. TEXHIf1\..1ECKIf1 YHIf1BEPCIf1TET KOIlEKTIf1BEH TPY.QOB.QOrOBOP HA TEXHIf1\..1ECKIf1 YHIf1BEPCIf1TET - COCDIf1f1 AHec, 18.03.2015 r., B rpaa COCPI!151Me>K,D,Y:PbKOBO,o,CTBOTO Ha TY - COCPI!151, npe,o,ctabn51baho OT pexropa nporp,,o,th

More information

Uniquely Human A Different Way to See Autism and Create Pathways to Success

Uniquely Human A Different Way to See Autism and Create Pathways to Success !"#$"#$ Special Agents of Change Spring 2015 Webinar Series Uniquely Human: A Different Way to See Autism and Create Pathways to Success Presenter: Barry M. Prizant, Ph.D., Childhood Communication Services

More information

Blood Types and Genetics

Blood Types and Genetics Blood Types and Genetics Human blood type is determined by codominant alleles. An allele is one of several different forms of genetic information that is present in our DNA at a specific location on a

More information

COMPLETE DOMINANCE. Autosomal Dominant Inheritance Autosomal Recessive Inheritance

COMPLETE DOMINANCE. Autosomal Dominant Inheritance Autosomal Recessive Inheritance COMPLETE DOMINANCE In complete dominance, the effect of one allele completely masks the effect of the other. The allele that masks the other is called dominant, and the allele that is masked is called

More information

1. npe.!vlaram Aa H3nbllHHM nopbykata nplil Clle,QH1!1Te YCllOBVISI:

1. npe.!vlaram Aa H3nbllHHM nopbykata nplil Clle,QH1!1Te YCllOBVISI: AO npeaceaa TEJl.R HA BbPXOBHM.R KACAI.lMOHEH CbA fp.cocpm.r, 6Yn.,BMTOWA" N22 TEXHM4ECKO npeano>kehme 3a npo&~~ypa 3a M36op Ha M3nbiiHMTen Ha o6lqecr8eha nop'b'fka 1.1pe3 ny6nm'iha nokaha, no ~ Ha rnaaa

More information

Complete Blood Count (CBC)

Complete Blood Count (CBC) Complete Blood Count (CBC) Objectives 1. To estimate the number of RBC in blood sample 2. To estimate the number of total WBC in blood sample 3. To perform a differential count for a blood sample Introduction

More information

1 h JUMl '< OUEDIREICTORATE" Technical Service No J.R. Gormly May 1991 Dallas Research Laboratory

1 h JUMl '< OUEDIREICTORATE Technical Service No J.R. Gormly May 1991 Dallas Research Laboratory 1 h JUMl '< OUEDIREICTORATE" GEOCHEMICAL EVALUATION OF OIL ISOLATED FROM WELL 6407/6-4, MIKKEL STRUCTURE, MID-NORWAY Technical Service No. 509-8277 J.R. Gormly May 1991 Dallas Research Laboratory ls3 TECHNICAL

More information

Pitfalls in the premarital testing for thalassaemia

Pitfalls in the premarital testing for thalassaemia Pitfalls in the premarital testing for thalassaemia Dr. Riad Amer MB ChB, MSc, FRCP, FRCPath, JBH Assistant Professor of Medicine Al Najah University Consultant Haematologist Case 1 Husband and Wife are

More information

l,lue CBETOCTIABT ylrl!1EB

l,lue CBETOCTIABT ylrl!1EB ABTO6HOTPAOl4fl Ilr,t'rHA rlhoopilat l[f, l,lue CBETOCTIABT...---.--ylrl!1EB AAp c Tene$or Oarc E-mail Haqrorannocr 6urapun Eara Ha pa{aahe 1967r. TPyAoB ctax. flpru (or-go) 21.11,2016r... l4me x aapec

More information

Med Chem 535P ~ Diagnostic Medicinal Chemistry. General Comments

Med Chem 535P ~ Diagnostic Medicinal Chemistry. General Comments Med Chem 535P ~ Diagnostic Medicinal Chemistry General Comments Most blood chemistry and serology assays are performed automatically. Larger clinical laboratories often use sophisticated analyzers that

More information

AEKJIAPAIII,I.f, fr;:nffi;::iorbparrbahe. l*... Q.. (rpure. Arrrxxocrra: rbprobcke lp5a(ecrba (uocowa ce rruero Ea rrprobckoro.

AEKJIAPAIII,I.f, fr;:nffi;::iorbparrbahe. l*... Q.. (rpure. Arrrxxocrra: rbprobcke lp5a(ecrba (uocowa ce rruero Ea rrprobckoro. Bril6ilruuM/// t flpuroneuue xru,tst. 72. r.2 AEKJIAPAIII,I.f, no sn. 12, r. 2 nrn apr:xa c,{o.ryuo4nrcauurr(u *rl i fr;:nffi;::iorbparrbahe...4/. /..y. Q.. (rpure l*... h-

More information

Day 15: Genetics. Insert Do Now

Day 15: Genetics. Insert Do Now Insert Do Now Guided Notes: Genetics and Punnet Squares 1. What is a purebred? (slide 1) 2. What are the two purebreds in this example? (slide 1) 3. What does dominant mean? (slide 1) 4. What is a phenotype?

More information

Beyond Mendel s Laws. Incomplete Dominance Co-dominance and Multiple Alleles

Beyond Mendel s Laws. Incomplete Dominance Co-dominance and Multiple Alleles Beyond Mendel s Laws Incomplete Dominance Co-dominance and Multiple Alleles Mendel s Studies He found that inherited traits were either dominant or recessive Dominant alleles expresses over the recessive

More information

,11;0. OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO PEIIIEHME

,11;0. OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO PEIIIEHME ,11;0 OEIJ:J;OTO C'bEPAH:UE HA C'b,[QI:UTE OT HAKA3ATEJIHATA KOJIErJiUI HA B'hPXOBHIDI KACAI(IIOHEH Cp)]; H C K A H E OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO

More information

VARIATION IN MEASUREMENT OF HIV RNA VIRAL LOAD

VARIATION IN MEASUREMENT OF HIV RNA VIRAL LOAD VARIATION IN MEASUREMENT OF HIV RNA VIRAL LOAD SOURCES OF VARIATION (RANDOM VS SYSTEMATIC) MAGNITUDE OF EACH SOURCE CONSEQUENCES FOR CONFIDENCE LIMITS AROUND MEASUREMENTS AND CHANGES DATA FROM ROCHE HIV

More information

Professor Eric Schulze-Bahr

Professor Eric Schulze-Bahr No CoI. Professor Eric Schulze-Bahr Institute for Genetics of Heart Diseases Department of Cardiology and Angiology University Hospital Münster / Germany ICD therapy in asymptomatic or borderline LQTS

More information

III. Ilpu.roxeH r{ AoKyMeHTrr. II. 3aqnreHrre 3a yqacrr.re B KoHKypc. PEUEH3lrrr

III. Ilpu.roxeH r{ AoKyMeHTrr. II. 3aqnreHrre 3a yqacrr.re B KoHKypc. PEUEH3lrrr PEUEH3lrrr OT rpoq..(unrurrp Hrrconoe 9onaxos 3a npucrngaue Ha akaaemirriha AJIbxHocr,rAoIIeHTt' Hayvua o6racr: 8.. I,lsxycrno Ilpor[ecnonaJrHo HarrpaBJreHue: S.2.Llso1pasr.rreirHo r{3kycrbo (I4:o6pasurelHo

More information

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc.

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. European Digestive Cancer Days, Prague - 26. September 2017 QUANTITATIVE FIT

More information

UNUSUAL PRESENTATION OF AN USUAL CAUSE OF THROMBOCYTOPENIA SOUTHERN RAILWAY HQ HOSPITAL, PERAMBUR DR. KUMARAN DNB PG

UNUSUAL PRESENTATION OF AN USUAL CAUSE OF THROMBOCYTOPENIA SOUTHERN RAILWAY HQ HOSPITAL, PERAMBUR DR. KUMARAN DNB PG UNUSUAL PRESENTATION OF AN USUAL CAUSE OF THROMBOCYTOPENIA SOUTHERN RAILWAY HQ HOSPITAL, PERAMBUR DR. KUMARAN DNB PG 5 months old female infant hailing from Thoothukudi brought by her mother referred from

More information

WO 2012/ A3. 15 November 2012 ( ) P O P C T

WO 2012/ A3. 15 November 2012 ( ) P O P C T (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International

More information

tr tr. ffti{, ,rep. sa ehepeuttnume xapakmepucmuku. br &H do.' r. Bueedeuae. Ha cepada e ekcnnoamaquf, \ / \.

tr tr. ffti{, ,rep. sa ehepeuttnume xapakmepucmuku. br &H do.' r. Bueedeuae. Ha cepada e ekcnnoamaquf, \ / \. ,rep @trptw@,wffiat a ehepettnme xapakmepcmk Ha cepada e ekcnnoamaqf, 363COoB4 br &H do.' 2.9.218r. crpar4e c n3ko Ao HynAro ioj- norpnhe na HprHn tr tr no xadacmp Beedeae Xrnlex 6nox 125, x.x Apyx6a-1,rp.

More information

The laws of Heredity. Allele: is the copy (or a version) of the gene that control the same characteristics.

The laws of Heredity. Allele: is the copy (or a version) of the gene that control the same characteristics. The laws of Heredity 1. Definition: Heredity: The passing of traits from parents to their offspring by means of the genes from the parents. Gene: Part or portion of a chromosome that carries genetic information

More information

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter Is cell morphology important? AML M7 CLL CD5 CD19 NHL

More information

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,

More information

OTOBOP. N./.2O17r. Co4iisi, Me)xy: 4HPKTOP a Pociva Fparopolla - HHHCOB ghpektop, napwiaa 3a KpaTKOCT

OTOBOP. N./.2O17r. Co4iisi, Me)xy: 4HPKTOP a Pociva Fparopolla - HHHCOB ghpektop, napwiaa 3a KpaTKOCT IP OTOBOP N./.2O17r. F InI Tn"nPABEH... Hec Co4iisi, Me)xy: 1. BTJIFAPCKATA HA1140HAJIHA TEJIEBH3IIH, cc cea.irnie a apec aa yripabjilehhe rp. Co4rn51, yi. "Caa CTedaHo" N2 29, c BYJICTAT 000672350, MAN

More information

Chapter 11. Introduction to Genetics

Chapter 11. Introduction to Genetics Chapter 11 Introduction to Genetics A Brief History In the past, people did not understand how traits were inherited, but there were many guesses based on things that could be observed. Two theories emerged.

More information

Appendix A: International Classification of Diseases, 10th Revision, Clinical Modification Codes (ICD-10) Utilized for VTE Events

Appendix A: International Classification of Diseases, 10th Revision, Clinical Modification Codes (ICD-10) Utilized for VTE Events Online Appendices to Mahan et al. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR) (Thromb Haemost 2014; 112.4) Appendix

More information

Friedewald formula. ATP Adult Treatment Panel III L D L Friedewald formula L D L = T- C H O - H D L - T G / 5. Friedewald formula. Friedewald formula

Friedewald formula. ATP Adult Treatment Panel III L D L Friedewald formula L D L = T- C H O - H D L - T G / 5. Friedewald formula. Friedewald formula Friedewald formula 1 1 1,2 ATP Adult Treatment Panel III L D L Friedewald formula L D L = T- C H O - H D L - T G / 5 Friedewald formula Friedewald formula 2003 99 Friedewald formula Colorimetric method

More information

PATIENT DRIVEN PAYMENT MODEL

PATIENT DRIVEN PAYMENT MODEL Fact Sheet: PDPM Patient Classification Last Revised: 2-14-19 Background Under PDPM, payment is determined through the combination of six payment components. Five of the components are case-mix adjusted,

More information

Health Equity and System in Nepal: Gloomy Achievements behind Bright Commitment

Health Equity and System in Nepal: Gloomy Achievements behind Bright Commitment Health Equity and System in Nepal: Gloomy Achievements behind Bright Commitment General Background Information of Nepal Population = 22,736,934 Male : 11,359,378 Female : 11,377,556 Largest Area District

More information

Mechanically actuated valves

Mechanically actuated valves Mechanically actuated valves /2-5/2 spool valves with /8 NPT threaded ports Installation in any position Comprehensive range of actuations, direct or servo-piloted Special versions on request Materials

More information

Trends in injecting drug use in Europe

Trends in injecting drug use in Europe Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information

More information

A Study on the Relationship between CBC and EEG for Epilepsy Patients

A Study on the Relationship between CBC and EEG for Epilepsy Patients ORIGINAL ARTICLE Korean J Clin Lab Sci. 2015, 47(4):225-229 http://dx.doi.org/10.15324/kjcls.2015.47.4.225 pissn 1738-3544 eissn 2288-1662 Korean J Clin Lab Sci. Vol. 47, No. 4, Dec. 2015 225 A Study on

More information

OEIUI,IHACOIIOT. 2. fiopaah feopruen KrHuee, EfH Ha ArraxHocr,,C[equalr4cr -

OEIUI,IHACOIIOT. 2. fiopaah feopruen KrHuee, EfH Ha ArraxHocr,,C[equalr4cr - OEIUI,ICOIIOT OE IIII,I HCKA MMI,IH H CTPAIII,IS yn. "l4ah a:oe" J{b34; ren. +359 3134/60-03; GSM: +359 887 359 4l I Fax: +359 3134176-60; e-mail: oa_sopot@abv.bg; www.sopot-municipality.com TIPOTOKOJI

More information

Simple Songs for Modern Life

Simple Songs for Modern Life Full Score PRS Foundation Commission for Juice Vocal Ensemble Gabriel Prokofiev Sile Songs for Modern Life for Vocal trio (SSA) 2009 by Gabriel Prokofiev - Mute Song Ltd. 1 Albion Place, London WC6 0QT

More information

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at Cervical Cancer & HPV What is HPV Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. About HPV Theree are more than 100 types of HPV, of which at least 13 are cancer-causing

More information

NEW ONSET SYMPTOMS OF CONVERSION AFTER INCARCERATION. Anise Noggle, MD CPMC-PGY3 NCPS March 25, 2017

NEW ONSET SYMPTOMS OF CONVERSION AFTER INCARCERATION. Anise Noggle, MD CPMC-PGY3 NCPS March 25, 2017 NEW ONSET SYMPTOMS OF CONVERSION AFTER INCARCERATION Anise Noggle, MD CPMC-PGY3 NCPS March 25, 2017 Case Presentation ID: 25 YO male with 3 weeks of b/l LE weakness, dysarthria, memory loss, paresthesias.

More information

Feedback from review of child TB in south east Asia

Feedback from review of child TB in south east Asia Feedback from review of child TB in south east Asia Viet Nam Situational analysis - 2011: Child TB < 2% of total burden - despite high prevalence (307/100,000) on recent survey research on TB meningitis

More information

Blood transfusion as a management strategy for Haemoglobinopathy. Corrina McMahon Our Lady s Children s Hospital, Dublin, Ireland

Blood transfusion as a management strategy for Haemoglobinopathy. Corrina McMahon Our Lady s Children s Hospital, Dublin, Ireland Blood transfusion as a management strategy for Haemoglobinopathy Corrina McMahon Our Lady s Children s Hospital, Dublin, Ireland Rationale for BT Sickle cell Disease Reduce the production of Hb Significant

More information

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD

More information

Comprehensive Approach to DLB Management

Comprehensive Approach to DLB Management Comprehensive Approach to DLB Management Bradley F. Boeve, MD Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Comprehensive Approach to DLB Management Disclosures

More information

RSG 18 LFCA RSG 24 LFCA

RSG 18 LFCA RSG 24 LFCA RSG 18 LFCA RSG 24 LFCA При всякакви проблеми, които не може да определите или отстраните, потърсете помощта на упълномощеният регионален сервиз: гр. Пловдив, бул."кукленско шосе" 52, тел. 032 / 390 102,

More information

Case scenarios in Pediatric Hematology and Oncology. Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital

Case scenarios in Pediatric Hematology and Oncology. Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital Case scenarios in Pediatric Hematology and Oncology Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital Objectives * To discuss and learn initial features of childhood leukemia.

More information

Scenario #4A: Geriatric Trauma Resuscitation Version-5

Scenario #4A: Geriatric Trauma Resuscitation Version-5 Scenario #4A: Geriatric Trauma Resuscitation Version-5 Goals & Objectives: 1. Discuss the principles of initial assessment of a geriatric trauma patient. 2. Recognize physiologic and anatomic changes that

More information

Case conference. TAKUGA HINOSHITA 2 nd resident ONMC

Case conference. TAKUGA HINOSHITA 2 nd resident ONMC Case conference TAKUGA HINOSHITA 2 nd resident ONMC 38 y/o female, Japanese CC: Dyspnea, Muscle clump, Numbness HPI Since 1 week PTA, she s been complaining of fever around 38, chills, cold sweat and nocturnal

More information

a) Determine the HgB values for the patient samples to fill in the table below. (15 points total) (g/dl) (%) 1 (Female)

a) Determine the HgB values for the patient samples to fill in the table below. (15 points total) (g/dl) (%) 1 (Female) Week 4 - PROBLEM SET ( 200 points ) INSTRUCTIONS: Report all numerical answers to 1 decimal place. Do not round values used for calculations. Must show calculations and units for full credit. (1) A standard

More information

Chao Phya Abhaibhubejhr Hospital. Sharing the Herbal Heritage of Thai Wisdom

Chao Phya Abhaibhubejhr Hospital. Sharing the Herbal Heritage of Thai Wisdom Chao Phya Abhaibhubejhr Hospital Sharing the Herbal Heritage of Thai Wisdom Prachinburi Province Prachinburi Prachinburi Province Located in the eastern part of Thailand. The distance from BKK is 130 Km.

More information

Viruses in May RCAP- Katoomba. Nigel Crawford

Viruses in May RCAP- Katoomba. Nigel Crawford Viruses in May RCAP- Katoomba Nigel Crawford Rotavirus and other. vaccinations, outcomes and experiences in high-risk groups Presentation outline 1. Special risk Definitions Immune suppression 2. Vaccines:

More information

The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting

The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting Evropská unie Evropský sociální fond Operační program Zaměstnanost Regional reporting of

More information

Brooks Rand Labs Detection & Reporting Limits Biota

Brooks Rand Labs Detection & Reporting Limits Biota Biota %TS SM 2540G 0.30 1.00 % 0.020 0.100 mg/kg Al 0.14 0.80 mg/kg 0.11 0.30 mg/kg DRC 0.014 0.040 mg/kg (III) (Inorg) (Org) 0.05 0.16 mg/kg (Org) DRC 0.014 0.040 mg/kg () B 0.24 0.80 mg/kg Ba 0.03 0.16

More information

LavaCell. Fluorescent Cell Stain. (version A) Catalog No

LavaCell. Fluorescent Cell Stain. (version A) Catalog No LavaCell Fluorescent Cell Stain (version A) Catalog No. 15004 Active Motif North America 1914 Palomar Oaks Way, Suite 150 Carlsbad, California 92008, USA Toll free: 877 222 9543 Telephone: 760 431 1263

More information

The diagnosis of Hemoglobinopathies

The diagnosis of Hemoglobinopathies 1ST IFCC, EFLM, AFCB CONFERENCE "LABORATORY MEDICINE: MEETING THE NEEDS OF MEDITERRANEAN NATIONS" Rome, Italy 02/07/2018 The diagnosis of Hemoglobinopathies Dr Antonino Giambona Unit of Hematology of Rare

More information

Supplementary Information

Supplementary Information Supplementary Information - chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling Sun Mi Yun, Kwiyeom Yoon, Sunghoon Lee, Eunjeong Kim, Seong-Ho

More information

Heterotopic Ossification Excision Following Hip Arthroscopy

Heterotopic Ossification Excision Following Hip Arthroscopy Heterotopic Ossification Excision Following Hip Arthroscopy Molly A. Keegan, M.D. 3 John M. Redmond, M.D. 1,3 Asheesh Gupta, M.D. 1 Jon E. Hammarstedt, BA 1 Christine E. Stake, M.A. 1 Benjamin G. Domb,

More information

noachnima KbM 0MHAHCOBMTE ONETH

noachnima KbM 0MHAHCOBMTE ONETH "MEI1 HHBECT X011,14HHr "AA, ap. COOHR noachnima KbM 0MHAHCOBMTE ONETH HA " MEJ1 1111BECT xonimir" AA, SP.0043151 KbM 31 iliemembpm 2017 r. (npeocmaensream Hepa3dearra qacm om Ouriaricoeunin Ingram) 1.

More information

Is current first line ART good enough? Francois Venter Wits Reproductive Health & HIV Research Institute

Is current first line ART good enough? Francois Venter Wits Reproductive Health & HIV Research Institute Is current first line ART good enough? Francois Venter Wits Reproductive Health & HIV Research Institute Results: by April 2011 Budget: $3.5 billion 80% of 3,686 health facilities providing ARVs 50% ARV

More information

Ns.../._ r. HapHTiaHO IIO-HaTbK B ]XoroBopa 3a KpaTKOCT Ii3u1 JIHHTeJI, OT pyra ctpaha

Ns.../._ r. HapHTiaHO IIO-HaTbK B ]XoroBopa 3a KpaTKOCT Ii3u1 JIHHTeJI, OT pyra ctpaha y -/c9 AHec.fin...o Ns.../._...2017 r. rp. Coc wz, Me)KI yy 1. U16MAPCKATA IIAI1IOIIAJJHA TEJ1EB1 3W1, cc ce ianxiue H aapec Ha yrnpaanehhe rp. Cocjxsi, ya. "Cax CTe4axo" Ns 29, c 13YJICTAT 000672350,

More information

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

Preferred Clinical Services for Leading Age Florida August 26-27, 2015 DIAGNOSIS CODING ESSENTIALS FOR LONG-TERM CARE: CHAPTER 3, D CODES DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS AND CERTAIN DISORDERS INVOLVING THE IMMUNE MECHANISM Preferred Clinical Services for Leading

More information

Laboratory Testing for the Primary Care Optometrist

Laboratory Testing for the Primary Care Optometrist General lab principles Indications for testing - Confirm a clinical diagnosis - Rule out a diagnosis - Manage a disease - Screen for a disease Sensitivity is the ability to show a positive result in a

More information

OTQET. 3a pa60tata Ha 061.IJ,eCTBeHHH nocpe,lj,hhk Ha 061.IJ,HHa Ka3aHJI'hK 3a 2010 ro,lj,hha

OTQET. 3a pa60tata Ha 061.IJ,eCTBeHHH nocpe,lj,hhk Ha 061.IJ,HHa Ka3aHJI'hK 3a 2010 ro,lj,hha ~: OTQET a pa0tata Ha 01.J,eCTBeHHH nocpe,lj,hhk Ha 01.J,HHa KaaHJ'hK a 010 ro,lj,hha HaCT0lmmlT OTQeT ce MrOTB Ha OCHOBaHMe llj., an. M OT TpaBMJHMKa a oprahmal(mta M.n:eMHocTTa Ha 0mecTBeHM nocpe.n:hmk

More information

PETIYliJIHKA li'bjir APH.SI. MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe. OliRBA

PETIYliJIHKA li'bjir APH.SI. MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe. OliRBA PETIYliJIHKA li'bjir APH.SI MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe OEJIACTHA )J)1PEKlJ)15I "3EME,UEJII1E" - OEmI1HCKA CJIY}KEA ITO 3EME,UEJII1E - IIJIEBEH IIJIEBEH 5800,rp.n.neaeH, y.n. "BaCV1.n neackv1"

More information

EVOLUTIONARY GENETICS LAB PROBLEMS

EVOLUTIONARY GENETICS LAB PROBLEMS ANTHR 1-L: Bio Anthro Lab Name: EVOLUTIONARY GENETICS LAB PROBLEMS 1. In Likis, a type of monkey (hypothetical), a single dominant allele determines whether or not a Liki is spotted (S) or not (nonspotted

More information

NONALLELIC GENE INTERACTIONS POLYGENIC INHERITANCE

NONALLELIC GENE INTERACTIONS POLYGENIC INHERITANCE NONALLELIC GENE INTERACTIONS POLYGENIC INHERITANCE 1 st year, 2nd semester, week 13 May 12, 13, and 14, 2008 Aleš Panczak, ÚBLG 1. LF a VFN Albinism coat colour in the rat P SHR x BN genotype ccbb CCbb

More information

Does Obesity Affect Outcomes in Hip Arthroscopy? A Matched-Pair Controlled Study with 2-year Minimum Follow-up

Does Obesity Affect Outcomes in Hip Arthroscopy? A Matched-Pair Controlled Study with 2-year Minimum Follow-up Does Obesity Affect Outcomes in Hip Arthroscopy? A Matched-Pair Controlled Study with 2-year Minimum Follow-up Asheesh Gupta, MD 1 John M. Redmond MD 1,3 Jon E. Hammarstedt, BS 1 Christine E. Stake, DHA

More information

Recent Minima of 161 Eclipsing Binary Stars

Recent Minima of 161 Eclipsing Binary Stars Samolyk, JAAVSO Volume 38, 2010 85 Recent Minima of 161 Eclipsing Binary Stars Gerard Samolyk P.O. Box 20677; Greenfield, WI 53220; gsamolyk@wi.rr.com Received September 23, 2009; accepted September 25,

More information

PEIIIEHUE. PEIIYEJII.{KA EbJIIAPII-g IIHCTIEKTOPAT KbM BIICI}Ifl CbAEBEH CbBET

PEIIIEHUE. PEIIYEJII.{KA EbJIIAPII-g IIHCTIEKTOPAT KbM BIICI}Ifl CbAEBEH CbBET PEIIYEJII.{KA EbJIIAPII-g IIHCTIEKTOPAT KbM BIICI}Ifl CbAEBEH CbBET rp. CoOHs 1000, yn.,,feopr Baruunr, on" Nl I 7, ren./$axc 02 905 75 03 Hs*. r,{b.(.r :.Q[.: /tl Lara,.kfl,9h.,.3O(Yu PEIIIEHUE Teo,4opa

More information

Soft Supports (Ready Made) Vendors

Soft Supports (Ready Made) Vendors AIRDRIE PHARMASAVE #338 101-209 CENTRE AVE SW AIRDRIE AB T4B 3L8 0000043698 001 UNIVERSAL HEALTH PHARMACY #6 3-1861 MEADOWBROOK DR SE AIRDRIE AB T4A 1V3 0000652930 001 BEISEKER BEISEKER PHARMACY 701 1

More information

BCR-ABL - LSK BCR-ABL + LKS - (%)

BCR-ABL - LSK BCR-ABL + LKS - (%) Marker Clone BCR-ABL + LSK (%) BCR-ABL + LKS - (%) BCR-ABL - LSK (%) P value vs. BCR-ABL + LKS - P value vs. BCR-ABL - LSK CD2 RM2-5 12.9 ± 3.6 36.7 ± 6.5 19.3 ± 2.4 0.01 0.10 CD5 53-7.3 13.9 ± 3.2 20.8

More information

Brief Communication Diagnostic Hematology

Brief Communication Diagnostic Hematology Brief Communication Diagnostic Hematology Ann Lab Med 2016;36:244-249 http://dx.doi.org/10.3343/alm.2016.36.3.244 ISSN 2234-3806 eissn 2234-3814 Establishment of Age- and Gender-Specific Reference Ranges

More information

ID NUMBER: CONTACT YEAR: FORM CODE: C E L VERSION G, DATE: 09/28/2015

ID NUMBER: CONTACT YEAR: FORM CODE: C E L VERSION G, DATE: 09/28/2015 ARIC Atherosclerosis Risk in Communities COHORT EVET ELIGIBILIT FORM ID UMBER: COTACT EAR: FORM CODE: C E L VERSIO G, DATE: 09/28/2015 ISTRUCTIOS: This form should be completed for all Cohort deaths, hospitalizations,

More information

Ascendens Christus in altum In Ascensione Domini

Ascendens Christus in altum In Ascensione Domini Ascendens Christus in altum In Ascensione Domini Tomàs Luis de Victoria (1572) Cantus A scen dens Chri stus in al tum, in al Quintus A scen dens Chri stus in al tum, Altus Tenor 8 A scen dens Chri stus

More information

Color: BROWN/WHITE. Protein test is performed and confirmed by the sulfosalicylic acid test.

Color: BROWN/WHITE. Protein test is performed and confirmed by the sulfosalicylic acid test. 5/8/2014 L 29 UA/Microscopy results from IDEXX Reference GLUCOSE NEGATIVE BILIRUBIN NEGATIVE KETONES NEGATIVE BLOOD NEGATIVE PH 6.5 SP GRAVITY 1.031 PROTEIN NEGATIVE UROB NORMAL WBC NONE SEEN HPF 0-5 RBC

More information

Unit 1 Review. 3. If the male parent had the following genotypes, what alleles would his gametes (sperm) contain? A. AABB B. AaBb C. aabb D.

Unit 1 Review. 3. If the male parent had the following genotypes, what alleles would his gametes (sperm) contain? A. AABB B. AaBb C. aabb D. Unit 1 Review 1. Define the following terms: a. Genotype b. Phenotype c. Dominant allele d. Recessive allele e. Homozygous f. Heterozygous g. Parental generation h. F1 generation i. Test cross j. Punnett

More information

Identification and Management of Hearing-Impaired Infants and Children: ABR, OAEs, Real-Ear Measurement, and Behavioral Testing

Identification and Management of Hearing-Impaired Infants and Children: ABR, OAEs, Real-Ear Measurement, and Behavioral Testing Kresge Hearing Research Laboratory Continuing Education Course Department of Otolaryngology Louisiana State University Health Sciences Center 533 Bolivar Street, Fifth Floor New Orleans, LA 70112 (504)

More information

Norovirus Surrogate Test Exposure to SixLog s ihp TM (ionized Hydrogen Peroxide) Decontamination Technology. Executive Summary:

Norovirus Surrogate Test Exposure to SixLog s ihp TM (ionized Hydrogen Peroxide) Decontamination Technology. Executive Summary: Norovirus Surrogate Test Exposure to SixLog s ihp TM (ionized Hydrogen Peroxide) Decontamination Technology Executive Summary: The ihp TM decontamination technology was used to kill a human norovirus surrogate

More information

npotokojl OT 3ACEAAHI!1E HA 06~0TO Cb6PAHI-1E HA AKI..\1!10HEPI-1TE HA "C!>OHA 3A HEABI!1>t<lr1MI!11!1MOTI-1 6bJlfAPI-1R" AACI!11..

npotokojl OT 3ACEAAHI!1E HA 06~0TO Cb6PAHI-1E HA AKI..\1!10HEPI-1TE HA C!>OHA 3A HEABI!1>t<lr1MI!11!1MOTI-1 6bJlfAPI-1R AACI!11.. I npotokojl OT 3ACEAAHI!1E HA 06~0TO Cb6PAHI-1E HA AKI..\1!10HEPI-1TE HA "C!>OHA 3A HEABI!1>tLilfl

More information

Host genotypes, inflammatory response and outcome of TBM Vietnam

Host genotypes, inflammatory response and outcome of TBM Vietnam Host genotypes, inflammatory response and outcome of TBM Vietnam Nguyen T.T. Thuong Oxford University Clinical Research Unit Ho Chi Minh City, Vietnam Tuberculous Meningitis (TBM) Diagnosis remains difficult

More information

M. Velizarova, T. Yacheva and K. Tzatchev Department of Clinical Laboratory and Clinical Immunology, MU Sofia

M. Velizarova, T. Yacheva and K. Tzatchev Department of Clinical Laboratory and Clinical Immunology, MU Sofia 50, 48, 2012, 3, ADVIA 2120.,.., ANALYSIS OF DIAGNOSTIC RED CELL CYTOGRAMS, GENERATED BY THE ADVIA 2120 HEMATOLOGY ANALYZER M. Velizarova, T. Yacheva and K. Tzatchev Department of Clinical Laboratory and

More information

Survey of blood transfusion-induced malaria and other diseases in Thalassemia patients from Solapur District (M.S.) India.

Survey of blood transfusion-induced malaria and other diseases in Thalassemia patients from Solapur District (M.S.) India. 7. CONCLUSION Over 125 patients affected by thalassemia live in Solapur District, Maharashtra, India. Thalassemia is a blood disease and is common in both sexes. Thalassemia was suspected in all these

More information

EVALUATIONWEB 2014 DIRECTLY FUNDED CBO CLIENT-LEVEL DATA COLLECTION TEMPLATE

EVALUATIONWEB 2014 DIRECTLY FUNDED CBO CLIENT-LEVEL DATA COLLECTION TEMPLATE General instructions for completing the EvaluationWeb Directly Funded CBO Client-Level Data Collection Template This data collection template is provided to assist community-based organizations that receive

More information

New treatment strategies in myelodysplastic syndromes and acute myeloid leukemia van der Helm, Lidia Henrieke

New treatment strategies in myelodysplastic syndromes and acute myeloid leukemia van der Helm, Lidia Henrieke University of Groningen New treatment strategies in myelodysplastic syndromes and acute myeloid leukemia van der Helm, Lidia Henrieke IMPORTANT NOTE: You are advised to consult the publisher's version

More information

Bay4ep11 3a xpaha Ha nepcoha. AOL 3a AOCTaBKa Ha 11eKapcTBeH11 noo11vkt11

Bay4ep11 3a xpaha Ha nepcoha. AOL 3a AOCTaBKa Ha 11eKapcTBeH11 noo11vkt11 .../'-,,.@3"'""'"..,o?, " -. \ -~_"''"".. { =ccl,' "- J/ ~ \ ~;l o_,.o~..,.11"11 MHOrOTIPOMJIHA 60JIHIIll,A 3A AKTHBHO JIEYEHHE " CBET A TIETKA " A.l( rp. B11)1;11H 3700, YJI. "ll,ap Cl1MEOH BEJIHKII"

More information

Human cell line list Production of Exosome Standards - Cell Lysates

Human cell line list Production of Exosome Standards - Cell Lysates Human cell line list 2016 - Production of Exosome Standards - Cell Lysates 380 peripheral blood leukemia, pre-b cell 1301 blood leukemia, acute lymphoblastic, T cell 5637 bladder carcinoma 8305C thyroid

More information